Search - tctmd.com

Displaying 381 - 400 of 419

Sort: Relevancy | Date

News Conference News ESC 2013

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Caitlin E. Cox

September 03, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Jason Kahn

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Yael L. Maxwell

October 10, 2012

News Daily News

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Caitlin E. Cox

October 09, 2012

News Daily News

Thrombus Aspiration Improves Clinical Outcomes in STEMI Patients

L.A. McKeown

September 26, 2012

News Daily News

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Caitlin E. Cox

September 20, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Sigue habiendo Problemas para Acortar los Tiempos de Reperfusión en Pacientes STEMI Trasladados

Yael L. Maxwell

August 15, 2012

News Daily News

Hurdles Remain in Shortening Reperfusion Times for Transferred STEMI Patients

Yael L. Maxwell

August 15, 2012

News Daily News

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

June 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

Advertisement

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Stroke After STEMI Unusual But Carries Poor Prognosis

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

Los Alelos Genéticos Influyen en la Respuesta al Prasugrel de los Pacientes víctimas de un SCA

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Los Índices de PCI para los IAM son Más Bajos en aquellos Estados que Facilitan Información

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Thrombus Aspiration Improves Clinical Outcomes in STEMI Patients

Early Aggressive Strategy in Elderly NSTE ACS Patients Not Harmful, Advantage Still Elusive

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Sigue habiendo Problemas para Acortar los Tiempos de Reperfusión en Pacientes STEMI Trasladados

Hurdles Remain in Shortening Reperfusion Times for Transferred STEMI Patients

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content